Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06223048
PHASE2

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

Sponsor: Amydis Inc.

View on ClinicalTrials.gov

Summary

The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).

Official title: A Phase 2, Randomized, Open Label Study of AMDX-2011P as a Retinal Tracer in Participants With Primary Open Angle Glaucoma

Key Details

Gender

All

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2023-12-07

Completion Date

2025-02

Last Updated

2024-07-30

Healthy Volunteers

No

Interventions

DRUG

AMDX-2011P

AMDX-2011P single bolus injection intravenous for diagnostic review

Locations (3)

Associated Retina Consultants

Phoenix, Arizona, United States

Global Research Management

Glendale, California, United States

Eye Research Foundation

Newport Beach, California, United States